The British period drama Majesty has become the focus of renewed attention after tabloid reports suggested the producers are seeking a trans woman to portray Queen Elizabeth I. On March 31, The Sun published an exclusive piece about the casting approach, and on April 2 a separate outlet shared what was presented as a casting brief requesting someone to play “the fantastic leading role of a young trans woman.” Those accounts, while unconfirmed by the broadcaster, have reignited wider discussions about how historical figures are dramatised and who gets to embody them on screen.
Origins of the idea and the controversies it revives
The casting chatter taps into long‑running, often sensational theories about Elizabeth’s identity. One persistent story, known as the Bisley Boy legend, claims that the princess who became Elizabeth died very young and was secretly replaced by a look‑alike boy. Other strands of speculation consider medical explanations such as testicular feminisation, a term used in some historical hypotheses to describe physical traits that would complicate traditional gender expectations. Most academic historians, however, treat these accounts as folklore or misogynistic attempts to explain a successful woman ruler by denying her female identity, and they largely dismiss them as credible reconstructions of Tudor reality.
What Majesty is and who is behind it
Majesty was first announced in 2026 as a six‑part series described by its creative team as a bold, speculative reimagining of Elizabeth’s youth and ascent to power. The project is being developed by former Grey’s Anatomy showrunners Joan Rater, Tony Phelan, and William Harper, who characterise the story as an alternate history that follows outsiders trying to survive while guarding a secret that could upend the nation. Producers have said the series aims to be emotional and contemporary in tone, using historical material to illuminate modern questions about identity, duty, and leadership. The show was greenlit in 2026 and is expected to reach screens in 2027, with reports that it was scheduled to begin production this summer.
Creative intent and the narrative frame
The writers and producers have emphasised that Majesty is not a documentary but a piece of speculative drama: an opportunity to imagine how certain rumours and conspiracies might have shaped the lives of those at court. In promotional statements they described the series as a way to play with history while reflecting current concerns about leadership and belonging. The creative pitch leans on the emotional stakes of concealment and the public consequences of private truths, asking whether a monarch’s hidden life could change how subjects remember an entire reign.
Reaction from commentators and the public
News that a trans woman might be considered for the role of Elizabeth prompted strong responses online and in some outlets. Some social media posts expressed anger and disbelief, arguing that such casting would rewrite a respected historical narrative. Others framed the idea as a provocative artistic choice or an overdue expansion of representation on screen. ITV, the broadcaster linked to the production, declined to comment publicly on casting details. Meanwhile, historians quoted by journalists reiterated that extraordinary claims require strong evidence and cautioned against allowing modern conjectures to substitute for archival scholarship.
Historical context and scholarly voices
Elizabeth’s own rhetoric complicated contemporary gender expectations: in one of her most famous speeches she told troops she had “the body of a weak and feeble woman, but I have the heart and stomach of a king,” a line often cited to show how she negotiated masculine and feminine roles in public life. In 2026, academic Dr Kit Heyam argued in an essay for Shakespeare’s Globe that Elizabeth sometimes used both male and female language to describe herself, suggesting a more fluid approach to identity. Still, mainstream Tudor scholarship continues to reject theories that rely on conspiratorial substitutions or retrospective medical diagnoses without primary evidence.</